Topotecan Plus M6620 (VX-970) vs. Topotecan Alone in People With Relapsed Small-Cell Lung Cancer
Conditions: Carcinoma, Small Cell; Solid Tumors; SCLC; Extrapulmonary Lung Cancer; Relapse Interventions: Drug: Topotecan + M6620; Drug: Topotecan Sponsor: National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials